Syndax has entered into a synthetic royalty funding agreement with Royalty Pharm...
Increasingly, injectable manufacturers recognise that to achieve maximum profita...
In an end-of-Phase II meeting, the FDA indicated support for accelerated approva...
The European Commission (EC) has imposed a fine of €462.6m ($502m) on Teva Pharm...
The US District Court upholds the FDA’s approval of Avadel’s Lumryz, dismissing ...
AbbVie has entered into a partnership and option-to-license agreement with Evolv...
Decentralized clinical trials are transforming medical research with more flexib...
The committee was not convinced that the benefit of Zynquista outweighed the ris...
Through a partnership, the NCCN is adapting its Harmonized Guidelines for cancer...
Verastem Oncology has concluded the rolling submission of a new drug application...
Roche first entered into an agreement with Orionis Biosciences in 2023 and paid ...
AbbVie has agreed to spend $1.4 billion to purchase Aliada Therapeutics. Through...
Izervay by Astellas and Syfovre by Apellis are the major rivals in the United St...
Apellis Pharmaceuticals and Novartis recently shared data for their rare kidney ...
With the formation of a new strategic partnership, Dyno Therapeutics is responsi...
Bladder cancer is the ninth most common cancer globally, and the number of diagn...
